Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JAK1 is a non-receptor tyrosine kinase essential for signal transduction of various cytokines, particularly type I and type II cytokines. It plays a critical role in the JAK-STAT signaling pathway, mediating cellular responses to interferons (IFN-alpha/beta/gamma), interleukins (IL-2, IL-4, IL-6 family), and other cytokines.
Inhibition of JAK1 kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine-protein kinase JAK1 (JAK1).